Customized Weight Loss Programs Tailored Just For You
Total Med Solutions has helped thousands of patients look and feel their best through our customized weight loss programs. These programs can help you achieve and maintain your weight loss goals, all at the most affordable prices you will find.
All our weight loss programs pricing are all-inclusive, so that you have complete cost transparency. Our pricing includes all consultations with your provider, detailed InBody composition analysis, all lab work, prescription costs and ongoing program maintenance.
Prescription Semaglutide/GLP-1 Weight Loss Programs
Total Med Solutions is a leader in providing Semaglutide/GLP-1 prescription weight loss programs to patients looking to lose weight. Our special prescription of Semaglutide/GLP-1 medication works through multiple mechanisms in your body to control appetite, reduce daily caloric consumption, and dramatically increase weight loss. Semaglutide/GLP-1 is a once-weekly injection that slows the stomach emptying, leading to a feeling of fullness and reduced hunger.
What Is Semaglutide/GLP-1
Semaglutide/GLP-1 Before & After
Tirzepatide/GLP-1, GIP
Total Med Solutions also offers dual agonist GLP/Cyanocobalamin weight loss programs that can cause people to lose even more weight. This GLP/Cyanocobalamin prescription weight loss program stimulates hormones that control blood sugar levels and reduce appetite, triggering weight loss. If you have a higher percentage of body fat, then our providers may recommend this for you.
GLP/Cyanocobalamin is an exciting new option for those struggling to lose weight through diet and exercise alone. If you are looking for a way to jumpstart your weight loss journey, GLP/Cyanocobalamin may be the right medication for you.
Recently, the FDA approved Tirzepatide for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity.
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical Care in the FDA’s Center for Drug Evaluation and Research. “This is a major step forward for patients with obstructive sleep apnea.”
OSA occurs when a person’s upper airway becomes blocked, causing pauses in breathing during sleep. While OSA can affect anyone, it is more common in people who have overweight or obesity. Tirzepatide works by activating receptors of hormones secreted from the intestine (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) to reduce appetite and food intake. By reducing body weight, studies show that Tirzepatide also improves OSA.
Book your GLP/Cyanocobalamin Weight Loss Consultation at Total Med today!
Tirzepatide/GLP-1, GIP Before & After
